• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination

tetano

Editor, Senior Moderator
Vaccine. 2016 Jun 24. pii: S0264-410X(16)30479-0. doi: 10.1016/j.vaccine.2016.06.055. [Epub ahead of print]
[h=1]Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.[/h] Kemmeren J[SUP]1[/SUP], Honsbeek M[SUP]2[/SUP], Dijkstra F[SUP]2[/SUP], de Lange M[SUP]2[/SUP], van der Maas N[SUP]2[/SUP], Smallenburg R[SUP]3[/SUP], Koppeschaar C[SUP]3[/SUP], van der Hoek W[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] During the 2009/2010 season, information on adverse events after administration of seasonal and pandemic influenza vaccines was collected by different active surveys in the Netherlands. In the present paper, we compared data from a paper-based questionnaire with data from a web-based questionnaire with respect to outcomes and target population, in order to guide future influenza vaccine safety monitoring.
[h=4]METHODS:[/h] The paper-based survey collected data from patients who attended primary care practices in the province of Utrecht for influenza vaccination. The web-based survey recruited participants from the general population all provinces of the Netherlands. To analyze the association between study approach and the reported local and systemic adverse events, a generalized estimation equation model was applied. We adjusted for age, gender, comorbidity, previous vaccination and socio-economic status score.
[h=4]RESULTS:[/h] No significant differences were found between the two studies approaches in reporting local reactions (OR: 0.98, 95% CI 0.88-1.10) and systemic AEs (OR: 1.12, 95% CI 0.99-1.27). There were important differences in the age groups that responded. The elderly were more represented in the paper-based survey where participants were recruited via GPs (79%⩾60years) compared to 37% in the web-based survey where participants were recruited via internet.
[h=4]CONCLUSION:[/h] The paper-based survey with recruitment of participants through GPs is more representative for the target group of influenza vaccination compared to the web-based survey with recruitment of participants via internet. A web-based approach with recruitment of participants via internet seems more suitable for situations where information about adverse events on a national level is desirable. We recommend to recruit participants for a web-based survey during mass vaccinations sessions by GPs to comply with the recommendations of the European Centre for Disease Prevention Control.
Copyright ? 2016 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Influenza vaccine; Pandemic vaccine; Paper-based; Questionnaire; Safety monitoring; Web-based

PMID: 27349839 DOI: 10.1016/j.vaccine.2016.06.055
[PubMed - as supplied by publisher]
 
Back
Top Bottom